Perinatal Fentanyl Exposure Drives Enduring Addiction Risk and Central Amygdala Gene Dysregulation

Written By Stellate Comms

Courtney P. Wood, Yeji Shin, Maria G. Balaguer, Paola Campo, Selen Dirik, Bryan A. Montoya, Gregory M. R. Cook, Gabrielle M. Palermo, Parsa K. Naghshineh, Alex Morgan, Sara R. M. U. Rahman, Abraham A. Palmer, Francesca Telese, Giordano de Guglielmo. (2025). Neuropharmacology, https://doi.org/10.1016/j.neuropharm.2025.110581.

Stellate Comms

Stellate is a full-service, strategic communications firm. We sit at the intersection of science and everything it touches: health, technology, art, culture, community, and the greater human good. We work with the visionaries, innovators, scientists, and funders who are improving human health, protecting our planet, and moving society forward.

https://stellatecomms.com
Previous

Long-Term Effects of Adolescent 5F-MDMB-PICA Intravenous self-administration: Neurobehavioral Consequences and medial Prefrontal Cortex Dysfunction in Adult Mice
Next

Perinatal Fentanyl Exposure Drives Enduring Addiction Risk and Central Amygdala Gene Dysregulation